Homebiotech

biotech

biotech

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

Jim Cornall - April 9, 2026

biotech

Positive results from moderate-to-severe atopic dermatitis trial

Jim Cornall - April 8, 2026

biotech

Centessa Pharmaceuticals to be acquired by Lilly

Jim Cornall - April 8, 2026

biotech

Smart drugs to fight cancer

Jim Cornall - April 8, 2026

biotech

Unstable protein understanding key to new treatments

Jim Cornall - November 27, 2025

biotech

New immune process identified that may alleviate Alzheimer’s disease

Jim Cornall - November 27, 2025

biotech

Calcium-sensitive switch boosts cancer drugs’ efficacy

Jim Cornall - November 26, 2025

biotech

$120m investment to grow talent and innovation in Virginia

Jim Cornall - November 26, 2025

biotech

Potential of enzymatic single-stranded DNA for non-viral gene editing

Jim Cornall - November 26, 2025

biotech

The next era of CGT

Jim Cornall - November 25, 2025

biotech

FDA approves PADCEV plus Keytruda for certain patients with bladder cancer

Jim Cornall - November 25, 2025

biotech

‘Groundbreaking’ rapid diagnostic test for prostate cancer

Jim Cornall - November 25, 2025

1...272829...68 Page 28 of 68

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

Jim Cornall - April 9, 2026 0

Armatus Bio has announced the publication of foundational data in Molecular Therapy Nucleic Acids describing the safety and biodistribution impact of TVR110, a first-in-class...

Positive results from moderate-to-severe atopic dermatitis trial

biotech Jim Cornall - April 8, 2026 0

Centessa Pharmaceuticals to be acquired by Lilly

biotech Jim Cornall - April 8, 2026 0

Smart drugs to fight cancer

biotech Jim Cornall - April 8, 2026 0

OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery

biotech Jim Cornall - April 7, 2026 0